The global blood group typing market is set for robust growth, reaching an estimated USD 3.73 billion by 2031. This translates to a compelling compound annual growth rate (CAGR) of 8.8% during the forecast period of 2024-2031, according to industry analysis.
Key Players
The major key players are Grifols, S.A, Merck KGaA, Bio-Rad Laboratories, Inc., Immucor, Inc., Novacyt Group, Danaher Corporation, Agena Bioscience, Inc, Ortho Clinical Diagnostics, Quotient. Ltd, Bio-Rad Laboratories, Inc, Quidelortho and others.
Market Analysis
Several key drivers are fueling the blood group typing market expansion:
- Increasing Blood Transfusion Demand: The rising need for blood transfusions in surgeries, accident cases, and blood disorders is a significant growth factor. Safe and accurate blood group typing is crucial for compatible transfusions.
- Growing Geriatric Population: As the global population ages, the prevalence of chronic diseases requiring blood transfusions is expected to rise, propelling market growth.
- Advancements in Technology: Development of automated blood typing instruments and rapid test kits is enhancing efficiency and accuracy, leading to greater adoption.
- Rising Prenatal Testing: Blood group typing plays a vital role in prenatal care to identify potential complications during pregnancy.
KEY MARKET SEGMENTATION
By Product
- Consumables
- Instruments
- Services
By Technique
- PCR-based and Microarray Techniques
- Assay-based Techniques
- Massively Parallel Sequencing Techniques
- Other Techniques
By Test Type
- Antibody Screening
- HLA Typing
- Cross-matching Tests
- ABO Blood Tests
- Antigen Typing
Impact of the Russia-Ukraine Conflict
The ongoing conflict presents potential challenges like supply chain disruptions and fluctuating resource costs. However, the critical role of blood group typing in healthcare is expected to minimize the long-term impact.
The Impact of Economic Slowdown
An economic slowdown could lead to increased scrutiny on healthcare spending. However, the essential nature of blood group typing procedures in critical care situations is likely to buffer the market from significant downturns.
Regional Analysis
North America is expected to hold a dominant market share due to advanced healthcare infrastructure, high adoption rates of new technologies, and supportive government policies. The Asia Pacific region is projected to witness the fastest growth due to a burgeoning population, rising healthcare awareness, and increasing disposable incomes.
Key Takeaways
- The blood group typing market is poised for significant growth driven by the rising demand for blood transfusions, technological advancements, and wider adoption in prenatal care.
- While the Russia-Ukraine conflict and potential economic slowdowns may pose temporary challenges, the market’s long-term outlook remains positive.
- Regional growth will likely be strongest in Asia Pacific due to its expanding healthcare sector and growing population.
This press release provides a snapshot of the blood group typing market. In-depth market research reports can offer a more comprehensive understanding of market dynamics and future trends.
Other Trending Report
Central Nervous System Treatment Market Share
Fibromyalgia Treatment Market Share
Huntington’s Disease Treatment Market Share
Autism Spectrum Disorder Treatment Market Share
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
info@snsinsider.com
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)
Website: https://www.snsinsider.com
